{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:35:54Z","timestamp":1729226154639,"version":"3.27.0"},"edition-number":"1","reference-count":123,"publisher":"European Respiratory Society","isbn-type":[{"type":"print","value":"9781849841696"},{"type":"electronic","value":"9781849841719"},{"type":"electronic","value":"9781849841702"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.1183\/2312508x.10025422","type":"book-chapter","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T16:20:17Z","timestamp":1692980417000},"source":"Crossref","is-referenced-by-count":0,"title":["Protecting the most vulnerable: tuberculosis in immunocompromised individuals"],"prefix":"10.1183","author":[{"given":"Eg\u00eddio","family":"Torrado","sequence":"first","affiliation":[]},{"given":"Reinout","family":"vanCrevel","sequence":"additional","affiliation":[]},{"given":"Ana Raquel","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"Diana","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[]}],"member":"81","reference":[{"journal-title":"WHO Operational Handbook on Tuberculosis. Module 1: Prevention \u2013 Tuberculosis preventive Treatment","year":"2020","key":"2023082509200664000_9781849841702.1.chapter_16.1"},{"key":"2023082509200664000_9781849841702.1.chapter_16.2","doi-asserted-by":"crossref","first-page":"e4165","DOI":"10.7717\/peerj.4165","article-title":"CD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis","volume":"5","year":"2017","journal-title":"PeerJ"},{"key":"2023082509200664000_9781849841702.1.chapter_16.3","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies Registry","volume":"60","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2023082509200664000_9781849841702.1.chapter_16.4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2023082509200664000_9781849841702.1.chapter_16.5","doi-asserted-by":"crossref","first-page":"727220","DOI":"10.3389\/fimmu.2022.727220","article-title":"Increased tuberculosis incidence due to immunotherapy based on PD-1 and PD-L1 blockade: a systematic review and meta-analysis","volume":"13","year":"2022","journal-title":"Front Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.6","doi-asserted-by":"crossref","first-page":"1759720X2093011","DOI":"10.1177\/1759720X20930116","article-title":"Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors","volume":"12","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.7","doi-asserted-by":"crossref","first-page":"e0187967","DOI":"10.1371\/journal.pone.0187967","article-title":"Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"2023082509200664000_9781849841702.1.chapter_16.8","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S1473-3099(17)30623-0","article-title":"Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives","volume":"18","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.coi.2021.07.001","article-title":"Mycobacterial diseases in patients with inborn errors of immunity","volume":"72","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ng.3248","article-title":"Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration","volume":"47","year":"2015","journal-title":"Nat Genet"},{"key":"2023082509200664000_9781849841702.1.chapter_16.11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ng.3498","article-title":"HLA class II sequence variants influence tuberculosis risk in populations of European ancestry","volume":"48","year":"2016","journal-title":"Nat Genet"},{"key":"2023082509200664000_9781849841702.1.chapter_16.12","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.201407-1385OC","article-title":"Cigarette smoking impairs human pulmonary immunity to Mycobacterium tuberculosis","volume":"190","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.13","first-page":"10.1128\/microbiolspec.TNMI7-0023","article-title":"Diabetes and tuberculosis","volume":"4","year":"2016","journal-title":"Microbiol Spectr"},{"key":"2023082509200664000_9781849841702.1.chapter_16.14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1186\/s12889-021-10711-1","article-title":"The association between silica exposure, silicosis and tuberculosis: a systematic review and meta-analysis","volume":"21","year":"2021","journal-title":"BMC Public Health"},{"key":"2023082509200664000_9781849841702.1.chapter_16.15","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI38482","article-title":"Anti-TNF immunotherapy reduces CD8+ T cell\u2013mediated antimicrobial activity against Mycobacterium tuberculosis in humans","volume":"119","year":"2009","journal-title":"J Clin Invest"},{"key":"2023082509200664000_9781849841702.1.chapter_16.17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","article-title":"Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection","volume":"16","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1146\/annurev-immunol-042617-053420","article-title":"The immune response to Mycobacterium tuberculosis in HIV-1-coinfected persons","volume":"36","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tube.2016.02.010","article-title":"HIV-1 and the Mycobacterium tuberculosis granuloma: a systematic review and meta-analysis","volume":"98","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"2023082509200664000_9781849841702.1.chapter_16.20","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood-2009-12-259473","article-title":"Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments","volume":"115","year":"2010","journal-title":"Blood"},{"key":"2023082509200664000_9781849841702.1.chapter_16.21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1083\/jcb.200903070","article-title":"Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages","volume":"186","year":"2009","journal-title":"J Cell Biol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.22","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1074\/jbc.M109.073320","article-title":"Exogenous Nef is an inhibitor of Mycobacterium tuberculosis-induced tumor necrosis factor-alpha production and macrophage apoptosis","volume":"285","year":"2010","journal-title":"J Biol Chem"},{"key":"2023082509200664000_9781849841702.1.chapter_16.23","first-page":"A475","article-title":"Linking TB and the environment: an overlooked mitigation strategy","volume":"116","year":"2008","journal-title":"Environ Health Perspect"},{"key":"2023082509200664000_9781849841702.1.chapter_16.24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5588\/ijtld.19.0002","article-title":"The impact of smoking on tuberculosis treatment outcomes: a meta-analysis","volume":"24","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nri2530","article-title":"How cigarette smoke skews immune responses to promote infection, lung disease and cancer","volume":"9","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1165\/rcmb.2013-0523OC","article-title":"Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells","volume":"51","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.00709-10","article-title":"Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis","volume":"79","year":"2011","journal-title":"Infect Immun"},{"key":"2023082509200664000_9781849841702.1.chapter_16.28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cell.2016.02.034","article-title":"Lysosomal disorders drive susceptibility to tuberculosis by compromising macrophage migration","volume":"165","year":"2016","journal-title":"Cell"},{"key":"2023082509200664000_9781849841702.1.chapter_16.29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tube.2017.08.012","article-title":"Alveolar macrophages from tuberculosis patients display an altered inflammatory gene expression profile","volume":"107","year":"2017","journal-title":"Tuberculosis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1172\/JCI200421146","article-title":"Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice","volume":"114","year":"2004","journal-title":"J Clin Invest"},{"key":"2023082509200664000_9781849841702.1.chapter_16.31","doi-asserted-by":"crossref","first-page":"eaaw6693","DOI":"10.1126\/sciimmunol.aaw6693","article-title":"Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo","volume":"4","year":"2019","journal-title":"Sci Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41385-019-0156-2","article-title":"The human lung mucosa drives differential Mycobacterium tuberculosis infection outcome in the alveolar epithelium","volume":"12","year":"2019","journal-title":"Mucosal Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4049\/jimmunol.1100823","article-title":"Human lung hydrolases delineate Mycobacterium tuberculosis\u2013macrophage interactions and the capacity to control infection","volume":"187","year":"2011","journal-title":"J Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.34","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1042\/CS20220175","article-title":"Smoking-induced microbial dysbiosis in health and disease","volume":"136","year":"2022","journal-title":"Clin Sci"},{"key":"2023082509200664000_9781849841702.1.chapter_16.35","doi-asserted-by":"crossref","first-page":"e1009377","DOI":"10.1371\/journal.ppat.1009377","article-title":"Microbiome\u2013immune interactions in tuberculosis","volume":"17","year":"2021","journal-title":"PLoS Pathog"},{"key":"2023082509200664000_9781849841702.1.chapter_16.36","doi-asserted-by":"crossref","first-page":"626254","DOI":"10.3389\/fnut.2021.626254","article-title":"Microbiota and tuberculosis: a potential role of probiotics, and postbiotics","volume":"8","year":"2021","journal-title":"Front Nutr"},{"key":"2023082509200664000_9781849841702.1.chapter_16.37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2018.08.001","article-title":"Alveolar macrophages provide an early Mycobacterium tuberculosis niche and initiate dissemination","volume":"24","year":"2018","journal-title":"Cell Host Microbe"},{"key":"2023082509200664000_9781849841702.1.chapter_16.38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2020.03.010","article-title":"Commensal bacteria in the upper respiratory tract regulate susceptibility to infection","volume":"66","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clnu.2023.01.016","article-title":"Tuberculosis and malnutrition: the European perspective","volume":"42","year":"2023","journal-title":"Clin Nutr"},{"key":"2023082509200664000_9781849841702.1.chapter_16.40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12890-019-0953-0","article-title":"Nutritional status of tuberculosis patients, a comparative cross-sectional study","volume":"19","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.41","first-page":"286","article-title":"The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals","volume":"8","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.42","doi-asserted-by":"crossref","first-page":"14857","DOI":"10.1073\/pnas.93.25.14857","article-title":"Effects of protein calorie malnutrition on tuberculosis in\u2009mice","volume":"93","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023082509200664000_9781849841702.1.chapter_16.43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/CVI.00009-16","article-title":"Coexistent malnutrition is associated with perturbations in systemic and antigen-specific cytokine responses in latent tuberculosis infection","volume":"23","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1530-0277.1996.tb01059.x","article-title":"Alcohol modulates alveolar macrophage tumor necrosis factor-alpha, superoxide anion, and nitric oxide secretion in the rat","volume":"20","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"2023082509200664000_9781849841702.1.chapter_16.45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/IAI.00832-08","article-title":"Neutrophil recruitment to the lungs during bacterial pneumonia","volume":"77","year":"2009","journal-title":"Infect Immun"},{"key":"2023082509200664000_9781849841702.1.chapter_16.46","first-page":"1927","article-title":"Alcohol abuse, alcoholism, and damage to the immune system \u2013 a review","volume":"22","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"2023082509200664000_9781849841702.1.chapter_16.47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0741-8329(91)90187-2","article-title":"Effect of alcohol on spleen cells and their functions in C57BL\/6 mice","volume":"8","year":"1991","journal-title":"Alcohol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12762","article-title":"Influence of diabetes mellitus on immunity to human tuberculosis","volume":"152","year":"2017","journal-title":"Immunology"},{"key":"2023082509200664000_9781849841702.1.chapter_16.49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: a systematic review","volume":"9","year":"2011","journal-title":"BMC Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.50","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/s41598-021-81057-2","article-title":"Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis","volume":"11","year":"2021","journal-title":"Sci Rep"},{"key":"2023082509200664000_9781849841702.1.chapter_16.51","doi-asserted-by":"crossref","first-page":"1017024","DOI":"10.3389\/fpubh.2022.1017024","article-title":"Glycemic control and the risk of tuberculosis in patients with diabetes: a cohort study in a Mediterranean city","volume":"10","year":"2022","journal-title":"Front Public Health"},{"key":"2023082509200664000_9781849841702.1.chapter_16.52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1054\/tuld.1998.0167","article-title":"Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis","volume":"79","year":"1999","journal-title":"Tuber Lung Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tube.2012.10.003","article-title":"Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control","volume":"93","year":"2013","journal-title":"Tuberculosis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2017.03.017","article-title":"Immunological response to Mycobacterium tuberculosis infection in blood from type 2 diabetes patients","volume":"186","year":"2017","journal-title":"Immunol Lett"},{"key":"2023082509200664000_9781849841702.1.chapter_16.55","first-page":"299","article-title":"Functional state analysis of phagocytic cells of patients with type 2 diabetes and pulmonary tuberculosis","volume":"58","year":"2012","journal-title":"Clin Lab"},{"key":"2023082509200664000_9781849841702.1.chapter_16.56","doi-asserted-by":"crossref","first-page":"e0184753","DOI":"10.1371\/journal.pone.0184753","article-title":"Heightened circulating levels of antimicrobial peptides in tuberculosis \u2013 diabetes co-morbidity and reversal upon treatment","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"2023082509200664000_9781849841702.1.chapter_16.57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/etm.2014.2042","article-title":"Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis","volume":"9","year":"2015","journal-title":"Exp Ther Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.58","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/590565","article-title":"Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells","volume":"47","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1513\/AnnalsATS.201305-112OC","article-title":"Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines","volume":"10","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"2023082509200664000_9781849841702.1.chapter_16.60","first-page":"179","article-title":"The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes","volume":"15","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.61","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/infdis\/jit241","article-title":"Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus","volume":"208","year":"2013","journal-title":"J Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.62","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1183\/09031936.00226613","article-title":"Interferon-\u03b3 responses to Mycobacterium tuberculosis-specific antigens in diabetes mellitus","volume":"44","year":"2014","journal-title":"Eur Respir J"},{"key":"2023082509200664000_9781849841702.1.chapter_16.63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10096-007-0395-0","article-title":"The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus","volume":"27","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.64","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1440-1843.2012.02184.x","article-title":"Significance of the frequency of CD4+CD25+CD127\u2212 T-cells in patients with pulmonary tuberculosis and diabetes mellitus","volume":"17","year":"2012","journal-title":"Respirology"},{"key":"2023082509200664000_9781849841702.1.chapter_16.65","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(12)60235-9","article-title":"Silicosis","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"2023082509200664000_9781849841702.1.chapter_16.66","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/s41598-023-30012-4","article-title":"A mixed-methods study on impact of silicosis on tuberculosis treatment outcomes and need for TB-silicosis collaborative activities in India","volume":"13","year":"2023","journal-title":"Sci Rep"},{"key":"2023082509200664000_9781849841702.1.chapter_16.67","first-page":"465","article-title":"Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures","volume":"49","year":"1968","journal-title":"Br J Exp Pathol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.68","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4049\/jimmunol.0803642","article-title":"Airway delivery of silica increases susceptibility to mycobacterial infection in mice: potential role of repopulating macrophages","volume":"182","year":"2009","journal-title":"J Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.69","first-page":"177","article-title":"Tuberculosis risk factors in a silicotic cohort in Hong Kong","volume":"5","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1165\/ajrcmb.22.4.3599","article-title":"Interferon-\u03b3 production by specific lung lymphocyte phenotypes in silicosis in mice","volume":"22","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.71","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.72","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/clind\/15.3.540","article-title":"Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis","volume":"15","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.73","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri3210","article-title":"Interferon-inducible effector mechanisms in cell-autonomous immunity","volume":"12","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.74","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.chom.2017.07.005","article-title":"Innate immunity to intracellular pathogens: balancing microbial elimination and inflammation","volume":"22","year":"2017","journal-title":"Cell Host Microbe"},{"key":"2023082509200664000_9781849841702.1.chapter_16.75","first-page":"104ra102","article-title":"Vitamin D is required for IFN-\u03b3-mediated antimicrobial activity of human macrophages","volume":"3","year":"2011","journal-title":"Sci Transl Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.76","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.4049\/jimmunol.171.9.4689","article-title":"CD4+ T cells mediate IFN-\u03b3-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo","volume":"171","year":"2003","journal-title":"J Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.77","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4\u2005T cell mediated control of M. tuberculosis infection in vivo","volume":"7","year":"2011","journal-title":"PLoS Pathog"},{"key":"2023082509200664000_9781849841702.1.chapter_16.78","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.vaccine.2015.10.115","article-title":"Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"2023082509200664000_9781849841702.1.chapter_16.79","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/jiv055","article-title":"Interferon \u03b3 and tumor necrosis factor are not essential parameters of CD4 + T-cell responses for vaccine control of tuberculosis","volume":"212","year":"2015","journal-title":"J Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.80","doi-asserted-by":"crossref","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4\u2005T cell-derived IFN-\u03b3 plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease","volume":"12","year":"2016","journal-title":"PLoS Pathog"},{"key":"2023082509200664000_9781849841702.1.chapter_16.81","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023082509200664000_9781849841702.1.chapter_16.82","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-\u03b1 is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","year":"1995","journal-title":"Immunity"},{"key":"2023082509200664000_9781849841702.1.chapter_16.83","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3892\/etm.2016.3548","article-title":"Risk of tuberculosis during infliximab therapy for inflammatory bowel disease, rheumatoid arthritis, and spondyloarthropathy: a meta-analysis","volume":"12","year":"2016","journal-title":"Exp Ther Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.84","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s10067-017-3916-y","article-title":"Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol","volume":"37","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.85","first-page":"8909834","article-title":"Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics","volume":"2017","year":"2017","journal-title":"Mediator Inflamm"},{"key":"2023082509200664000_9781849841702.1.chapter_16.86","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.3346\/jkms.2022.37.e107","article-title":"The risk of tuberculosis in patients with inflammatory bowel disease treated with vedolizumab or ustekinumab in Korea","volume":"37","year":"2022","journal-title":"J Korean Med Sci"},{"key":"2023082509200664000_9781849841702.1.chapter_16.87","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/annrheumdis-2015-207319","article-title":"Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis","volume":"75","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.88","doi-asserted-by":"crossref","first-page":"eaau8714","DOI":"10.1126\/sciimmunol.aau8714","article-title":"Tuberculosis and impaired IL-23-dependent IFN-\u03b3 immunity in humans homozygous for a common TYK2 missense variant","volume":"3","year":"2018","journal-title":"Sci Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.89","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.chom.2021.02.005","article-title":"TGF\u03b2 restricts expansion, survival, and function of T cells within the tuberculous granuloma","volume":"29","year":"2021","journal-title":"Cell Host Microbe"},{"key":"2023082509200664000_9781849841702.1.chapter_16.90","first-page":"742","article-title":"EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","volume":"82","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.91","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023082509200664000_9781849841702.1.chapter_16.92","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1183\/09031936.00076714","article-title":"Prevalence, screening and treatment of latent tuberculosis among oral corticosteroid recipients","volume":"44","year":"2014","journal-title":"Eur Respir J"},{"key":"2023082509200664000_9781849841702.1.chapter_16.93","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases","volume":"183","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.94","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2147\/COPD.S209273","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with obstructive lung diseases: a systematic review and meta-analysis of non-randomized studies","volume":"14","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.95","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cmi.2017.12.003","article-title":"Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment","volume":"24","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2023082509200664000_9781849841702.1.chapter_16.96","doi-asserted-by":"crossref","first-page":"e002960","DOI":"10.1136\/jitc-2021-002960","article-title":"Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study","volume":"9","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2023082509200664000_9781849841702.1.chapter_16.97","doi-asserted-by":"crossref","first-page":"13402","DOI":"10.1073\/pnas.1007394107","article-title":"Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023082509200664000_9781849841702.1.chapter_16.98","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4049\/jimmunol.1003304","article-title":"CD4\u2005T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition","volume":"186","year":"2011","journal-title":"J Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.99","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41590-021-01121-x","article-title":"The immunoregulatory landscape of human tuberculosis granulomas","volume":"23","year":"2022","journal-title":"Nat Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.100","first-page":"e32068","article-title":"The prevalence of Mycobacterium tuberculosis infection among cancer patients receiving chemotherapy in a tertiary care center","volume":"14","year":"2022","journal-title":"Cureus"},{"journal-title":"Tuberculosis: Prevention, Diagnosis, Management and Service Organization","year":"2016","key":"2023082509200664000_9781849841702.1.chapter_16.101"},{"key":"2023082509200664000_9781849841702.1.chapter_16.102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s40425-019-0717-7","article-title":"Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations","volume":"7","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2023082509200664000_9781849841702.1.chapter_16.103","first-page":"124","article-title":"Tuberculosis in solid organ transplantation","volume":"15","year":"2016","journal-title":"Tanaffos"},{"key":"2023082509200664000_9781849841702.1.chapter_16.104","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/427692","article-title":"Mycobacterium tuberculosis infection in recipients of solid organ transplants","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.105","doi-asserted-by":"crossref","first-page":"210079","DOI":"10.1183\/20734735.0079-2021","article-title":"The definition of tuberculosis infection based on the spectrum of tuberculosis disease","volume":"17","year":"2021","journal-title":"Breathe (Sheff)"},{"issue":"Suppl. 1","key":"2023082509200664000_9781849841702.1.chapter_16.106","first-page":"S12","article-title":"The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection","volume":"124","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/annrheumdis-2011-200690","article-title":"Mycobacterial diseases and antitumour necrosis factor therapy in USA","volume":"72","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.108","doi-asserted-by":"crossref","first-page":"e137427","DOI":"10.1172\/jci.insight.137427","article-title":"Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis","volume":"5","year":"2020","journal-title":"JCI Insight"},{"key":"2023082509200664000_9781849841702.1.chapter_16.109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1142\/S2661341721500012","article-title":"Recommendations on management of latent tuberculosis infection in patients initiating anti-tumor necrosis factor biologics","volume":"21","year":"2021","journal-title":"J Clin Rheumatol Immunol"},{"key":"2023082509200664000_9781849841702.1.chapter_16.110","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.111","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.3390\/jcm11133915","article-title":"Performance of screening strategies for latent tuberculosis infection in patients with inflammatory bowel disease: results from the ENEIDA Registry of GETECCU","volume":"11","year":"2022","journal-title":"J Clin Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.112","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.autrev.2015.01.011","article-title":"Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice","volume":"14","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2023082509200664000_9781849841702.1.chapter_16.113","doi-asserted-by":"crossref","first-page":"e1549","DOI":"10.1016\/S2214-109X(22)00408-9","article-title":"Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV","volume":"10","year":"2022","journal-title":"Lancet Glob Health"},{"journal-title":"Global Tuberculosis Report 2019","year":"2019","key":"2023082509200664000_9781849841702.1.chapter_16.114"},{"key":"2023082509200664000_9781849841702.1.chapter_16.115","doi-asserted-by":"crossref","first-page":"20714","DOI":"10.7448\/IAS.19.1.20714","article-title":"TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis","volume":"19","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"2023082509200664000_9781849841702.1.chapter_16.116","doi-asserted-by":"crossref","first-page":"e022445","DOI":"10.1136\/bmjopen-2018-022445","article-title":"Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines","volume":"8","year":"2018","journal-title":"BMJ Open"},{"key":"2023082509200664000_9781849841702.1.chapter_16.117","unstructured":"Bracchi M, van Halsema C, Post F, et al. British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2018. Writing group members London School of Hygiene and Tropical Medicine BHIVA guidelines for the management of TB in adults living with HIV 2. British HIV Association, Letchworth, 2023."},{"key":"2023082509200664000_9781849841702.1.chapter_16.118","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/rheumatology\/key208","article-title":"The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis","volume":"58","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2023082509200664000_9781849841702.1.chapter_16.119","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2023082509200664000_9781849841702.1.chapter_16.120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.121","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis","volume":"380","year":"2019","journal-title":"N Engl J Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.122","doi-asserted-by":"crossref","first-page":"e1003703","DOI":"10.1371\/journal.pmed.1003703","article-title":"The latent tuberculosis cascade-of-care among people living with HIV: a systematic review and meta-analysis","volume":"18","year":"2021","journal-title":"PLoS Med"},{"key":"2023082509200664000_9781849841702.1.chapter_16.123","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41591-020-1076-0","article-title":"Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings","volume":"26","year":"2020","journal-title":"Nat Med"}],"container-title":["The Challenge of Tuberculosis in the 21st Century"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/2312508X.10025422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:14:20Z","timestamp":1729210460000},"score":1,"resource":{"primary":{"URL":"http:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/2312508X.10025422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"ISBN":["9781849841696","9781849841719","9781849841702"],"references-count":123,"alternative-id":["10.1183\/2312508X.erm10123"],"URL":"https:\/\/doi.org\/10.1183\/2312508x.10025422","relation":{},"subject":[],"published":{"date-parts":[[2023,9,1]]}}}